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Cardiovascular alterations are common in critically ill patients
and can have important implications for multiple organ
systems, including the kidney. Restoring and maintaining
adequate hemodynamic status in such patients is crucial
to ensure sufficient oxygen availability to tissues and organs
so that they can function optimally. In this text, we will
return to the basic physiology of cardiac output and its
components so that we can better understand the effects
of cardiovascular alterations in critically ill patients, and how
best to treat them.
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Many, if not all, disease processes encountered in intensive
care unit patients can impact directly or indirectly on
hemodynamics and cardiovascular status, including obvious
etiologies, such as myocardial infarction and cardiogenic
shock, and less apparent facets, such as the myocardial
depression of sepsis. Restoring and maintaining an adequate
and appropriate hemodynamic status in such patients is
crucial to ensure sufficient oxygen availability to tissues and
organs, including the kidneys, so that they can function
optimally. Oxygen delivery (DO2) is determined by cardiac
output and arterial oxygen content, which is itself deter-
mined by hemoglobin concentration and hemoglobin oxygen
saturation (Figure 1).
Cardiovascular problems are much more complex than
just a low or high arterial pressure or a low or high cardiac
output. In this text, we will return to the basic physiology of
cardiac output and its components so that we can better
understand the implications of cardiovascular alterations in
critically ill patients, and how best to treat them.
UNDERSTANDING CARDIAC OUTPUT
Cardiac output has four determinants—heart rate, contrac-
tility, preload, and afterload. To understand the individual
and combined impact of these four components, we have
suggested a simple analogy that equates the cardiac output,
i.e., the amount of blood pumped by the heart over a period
of time, to the speed of a bicycle1 (Figure 2).
The simplest determinant of cardiac output to visualize is
the heart rate, reflected by the speed of pedaling in our
analogy. There is an optimal speed at which a cyclist pedals—
both too slow and too fast are bad, but within a certain range
changing the pedaling speed will not influence the speed of
the bicycle very much. Similarly, altering heart rate is only
likely to benefit when the heart rate is very low or very high.
Increasing heart rate may impair left ventricular filling, and
hence reduce stroke volume, and can be deleterious because
heart rate is a fundamental determinant of the myocardial
oxygen demand (myocardial oxygen consumption is propor-
tional to the rate pressure product). Similarly, great care
should be taken when sinus tachycardia is observed, as it
usually represents either an adaptation to decreased stroke
volume or a means to achieve a supranormal cardiac output.
In either case, decreasing heart rate in isolation, without
treating the cause of the tachycardia, would result in a
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decrease in cardiac output that may alter tissue perfusion.
The optimal heart rate for each patient is, however, difficult
to determine, as it depends on intrinsic contractility, volume
status, adrenergic state, and diastolic function.
Contractility depends on the muscular force of contrac-
tion, and its implication is obvious. However, the force of
contraction is also a determinant of myocardial oxygen
demand, and increasing it may rapidly result in fatigue, as
with the cyclist pedaling too hard who eventually has to slow
and stop. This same situation can occur with excessive
inotropic support, and is associated with increased mortality
rates. This observation may explain why the long-term effects
of inotropic agents have been disappointing, but b-blocking
agents have been more beneficial in the long-term treatment
of patients with congestive heart failure. Short-term use of
inotropic agents may, however, be appropriately required for
treating inadequate cardiac output in the context of impaired
tissue perfusion, as the benefits may outweigh the myocardial
risks.
Preload is the degree of myocardial distension before
shortening, and can simplistically be compared with a
tailwind allowing the cyclist to move faster without any
additional muscular effort. Preload depends on volume status
and on diastolic function and time (and thus on heart rate).
Although preload is often already increased in patients with
established renal failure who have volume overload secondary
to oliguria, these patients also frequently have impaired
diastolic function related to myocardial muscle hypertrophy
and/or ischemic problems. It is noteworthy that during
hemodialysis, preload is often decreased as a consequence of
fluid withdrawal, and impaired cardiac function may explain
the poor tolerance to fluid withdrawal in some of these
patients. In particular, patients with diastolic dysfunction
have a poor therapeutic window between pulmonary edema,
due to increased hydrostatic pressure in lung capillaries, and
low stroke volume because of insufficient preload. In patients
with circulatory failure, optimization of preload should
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Figure 1 | The determinants of oxygen delivery. MVO2, myocardial oxygen consumption; PaO2, arterial partial pressure of oxygen; PEEP,
positive end-expiratory pressure; RV, right ventricular; SaO2, arterial oxygen saturation.
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Figure 2 |Representation of the four determinants of cardiac
output using as an analogy the speed of a bicycle (adapted
from Vincent1).
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always be considered. Clinically, this is accomplished by fluid
administration (see below).
Afterload represents the elements against which the
ventricles must work in order to eject blood, and is largely
dependent on arterial blood pressure and vascular tone. In
our analogy, decreasing afterload is similar to our cyclist
moving from a bumpy road to a smooth one or one with a
gentle downhill slope, where the bicycle’s speed can increase
significantly for the same degree of muscular effort. The tired
cyclist, or the failing heart, is particularly sensitive to these
aspects. The administration of strong vasopressors, such as
phenylephrine, may restore blood pressure but may decrease
cardiac output by increasing afterload, even in individuals
with normal cardiac function. This is observed especially if
hypovolemia coexists, which is why it is so important to
assess fluid requirements using a fluid challenge technique
(see below) in patients being treated with vasopressor agents.
Vasopressin may also decrease cardiac output by increasing
vascular tone.2,3 Similarly, vasodilators can increase cardiac
output, especially in conditions in which contractility is
impaired. This is why norepinephrine is usually preferred as a
vasoconstrictor: it is an effective vasoconstrictor because of
its a-adrenergic effects, yet it retains some inotropic effects
via its moderate b-adrenergic effects. Afterload is increased
(the road is now going uphill) but cardiac muscle contraction
is also increased (the cyclist pushes harder on the pedals).
Some drugs, such as phosphodiesterase inhibitors (milri-
none, enoximone) and levosimendan, exert combined
inotropic and vasodilating effects. This is similar to pushing
a bit harder on the pedals at the same time as the road starts
to go down; more exertion may lead to fatigue, but the
downhill slope helps maintain speed. This is why these
‘inodilating substances’ may increase myocardial oxygen
requirements less than other inotropic agents. However,
one has to be very cautious when using phosphodiesterase
inhibitors in patients with renal failure as their half-life is
markedly increased.
CARDIAC FUNCTION IN SEPSIS
In sepsis, the simultaneous presence of tachycardia and
reduced vascular tone results in reduced afterload, and
cardiac output can therefore be maintained or even increased.
Indeed, sepsis is typically associated with a high cardiac
output, a situation referred to as hyperkinetic or hyper-
dynamic (the two terms are equivalent). Fluid therapy is
typically necessary to achieve the hyperkinetic state. This
state is usually associated with a normal or high mixed
venous oxygen saturation reflecting decreased oxygen extrac-
tion by the tissues. Myocardial depression can occur
simultaneously, because of the release of cytokines and other
mediators, some of which are associated with abnormal
calcium handling by the cardiac myocytes,4,5 leading to
reduced myocardial contraction. There is evidence that the
more severe the sepsis, the more profound the vasodilation
and the myocardial depression. This situation is akin to the
cyclist being too tired to push on the pedals, but able to keep
up speed because of a strong tailwind and a smooth
downsloping road. Importantly, the severity of myocardial
depression is sometimes hidden by initial hypotension
(decreased afterload) and becomes obvious only after
restoration of blood pressure with vasoconstrictive agents.
DISTRIBUTION OF BLOOD FLOW
In acute conditions, when oxygen supply is threatened,
cardiac output is preferentially redistributed to the brain and
the heart. This is seen in low flow states, such as in acute
hemorrhage.6 In these acute conditions, the natural response
is to preserve the ability to think how to react and for the
heart to continue to pump as much flow as possible. Renal
blood flow is decreased as the resultant decrease in urine
production will help to preserve blood volume (an effect
that has been called ‘acute renal success’).7 Feeding is not a
priority in the acute conditions, and appetite is simulta-
neously reduced.
The persistence of decreased perfusion to the gut and the
kidneys is, however, an important preoccupation in critically
ill patients. It is expected that patients with persistent
hypovolemic or cardiogenic shock would have decreased
splanchnic and renal perfusion, but does this also occur in
patients with septic shock? Several studies have shown that
hepato-splanchnic perfusion is indeed altered in patients
with septic shock,8,9 and the severity of these alterations is
related to outcome. For renal perfusion, data are more scarce
and these provided conflicting results.10,11
MICROCIRCULATORY ALTERATIONS
The microcirculation has a key role in fine tuning perfusion
at the organ level. Several studies have shown that
microvascular perfusion is altered in sepsis12 or in severe
heart failure,13 even when global circulation is maintained at
resuscitation goals. Admittedly, evaluation of the renal
microcirculation is still not feasible in humans, but experi-
mental studies suggest that the renal microcirculation is
impaired in sepsis.
In addition, the kidney has some peculiarities; for
example, perfusion to the cortex, mainly containing
glomeruli, differs from that to the medulla, mainly contain-
ing tubules. Because of microcirculatory shunting, which
already occurs in normal conditions, the PO2 of the medulla
is markedly altered, whereas the PO2 of the cortex is close
to arterial PO2. Any decrease in renal perfusion will result
in a decrease in medullar PO2, which may reach critical
values for the very active tubular cells, leading to tubular
necrosis. In sepsis, alterations in renal microvascular per-
fusion, in conjunction with increased oxygen requirements in
the tubules,14 may contribute to renal failure even when total
renal perfusion is preserved.10
In fluid-resuscitated endotoxic animals, Johannes et al.15
reported that cortical and medullar PO2 decreased despite an
increase in renal perfusion. More recently, Legrand et al.16
reported in endotoxic rats that sepsis alters renal micro-
vascular perfusion and oxygenation distribution. More
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importantly, fluid administration, especially when performed
early, improved microvascular blood flow distribution but
failed to prevent the alteration in PO2 distribution.
Altogether, these data suggest impaired oxygen balance in
the kidneys, despite preservation of renal perfusion, especially
after fluid resuscitation.
KIDNEY PERFUSION: PRESSURE VS. FLOW
To ensure adequate oxygen delivery to the tissues, attempts
are often first made to optimize perfusion pressure and then
to optimize flow, but these two components may be directly
related. In normal conditions, organ blood flow remains
relatively constant over a wide range of pressures, because
autoregulation of blood flow induces vasoconstriction as
pressure increases and vasodilation when it decreases.
However, organ injury can impair this phenomenon, so that
organ blood flow becomes directly proportional to the
pressure in the organ.
In dogs, Bellomo et al.17 reported that endotoxin alters
renal autoregulation. For a given mean arterial pressure, renal
blood flow was lower in sepsis. Interestingly, administration
of norepinephrine increased pressure but decreased renal
perfusion in normal conditions, whereas it increased pressure
and renal perfusion in endotoxic conditions. In addition,
kidneys may be sensitive to flow. In an ovine model of septic
shock, the addition of levosimendan was associated with an
improvement in renal function, even though mean arterial
pressure was identical to that of the control group.18
Restoring or maintaining a sufficient perfusion pressure
should, therefore, be a first goal. There have been a number
of clinical reports showing that norepinephrine administra-
tion may increase urine output.19,20 Restoration of urine
output may be indicative of the optimal arterial pressure
level. But what is this optimal level? In patients with septic
shock, Martin et al.20 showed that increasing mean arterial
pressure from 54 to 75mmHg was associated with improved
urine output and creatinine clearance.21 However, Ledoux
et al.22 and Bourgoin et al.23 failed to observe significant
changes in urine output and/or creatinine clearance when
increasing mean arterial pressure from 65 to 75 and
85mmHg. Interestingly, there may be individual variability
in the response. When individual response rather than group
data were reported, it became obvious that some patients
may benefit from a further increase in blood pressure. Using
renal Doppler measures as a surrogate for renal blood flow,
Deruddre et al.24 observed that renal perfusion increased in
some but not all patients when increasing mean arterial
pressure from 65 to 75mmHg. This improvement in renal
Doppler was associated with an increase in urine output.
It is only when renal perfusion pressure has been restored
that increasing renal blood flow may be worthwhile. In
endotoxic shock, De Backer et al.25 reported that a low dose
of dobutamine (5mcg/kg/min) improved renal perfusion and
urine output. In patients with cardiac failure, a low-dose
dobutamine infusion also improved urine output. As renal
arteries have more dopaminergic receptors than the rest of
the body, the use of dopaminergic agents was believed to be a
rational approach;26 unfortunately, a large prospective
randomized controlled trial from Australasia did not show
any clinically measurable renal protection with low-dose
dopamine.27 More recently, in a large trial in which
vasopressor doses of dopamine and norepinephrine were
compared in the treatment of shock, dopamine administra-
tion did not result in improved renal function; moreover,
dopamine administration resulted in more arrhythmias than
did norepinephrine administration.28 In addition, dopamine
may decrease the immune response by preventing prolactin
release.29 The use of fenoldopam as a pure dopaminergic
agent may be an alternative, but this purely vasodilating
substance may decrease arterial pressure, which could limit
its use in critically ill patients.
Alternatively, one may consider increasing glomerular
filtration by preferential constriction of efferent arterioles.
This effect may explain why vasopressin—despite its natural
antidiuretic effects—may paradoxically increase urine output
and perhaps even creatinine clearance in patients with septic
shock.30 However, as mentioned above, one has to be very
cautious in the use of this agent, avoiding excessive increase
in arterial pressure, which may have detrimental effects on
heart function, and avoiding excessive doses, which can have
detrimental effects, including on splanchnic perfusion.
KIDNEY FUNCTION IN SEPSIS
Focusing only on the hemodynamic alterations is not
enough. Sepsis is a common cause of acute renal failure in
the critically ill,31 and hemodynamic stabilization in such
patients is often not sufficient. In contrast to earlier beliefs
that renal blood flow is decreased in sepsis, leading to renal
vasoconstriction and ischemia, more recent evidence indi-
cates that renal blood flow is typically increased in animal
models and at least normal in humans.10,11 Although
glomerular filtration is markedly reduced in septic acute
renal failure, pathologic studies have shown few structural
changes; those that are present are primarily restricted to the
tubular epithelium. Although endothelial and interstitial
changes may also occur, the histopathological alterations are
very limited, with hardly any evidence of tubular damage.
Hence, although microcirculatory disturbances may contri-
bute to an altered distribution of blood flow within the
kidneys, sepsis-related renal failure is rather an immune-
mediated phenomenon, associated with cytokine release,
increased nitric oxide formation, oxidative stress, mitochon-
drial damage, and increased apoptosis.11
IS SHOCK-RELATED ACUTE RENAL INSUFFICIENCY
PROTECTIVE?
As renal metabolism is highly energy demanding, some have
hypothesized that the shut down of renal function may be
adaptive, improving the balance between oxygen demand and
supply in renal cells.7 Indeed, as renal oxygen consumption is
mostly driven by sodium tubular readsorption, reduction in
glomerular filtration should lead to a reduction in the renal
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reabsorptive workload, and thus renal oxygen consumption.
This concept is supported by the fact that acute tubular
necrosis is uncommonly observed in patients with septic
shock. However, this idea has been challenged recently. In
post-cardiac surgery patients, renal oxygen consumption was
found to be similar in patients with and without acute renal
failure, whereas glomerular filtration, renal blood flow, and
sodium readsorption were found to be lower in patients with
acute renal failure than in the patients with normal renal
function.14 Accordingly, renal consumption per unit of
sodium reabsorbed in patients with renal dysfunction was
more than twice that in patients with normal renal function.
This suggests that renal dysfunction represents renal failure
more than renal success.
A PRACTICAL HEMODYNAMIC APPROACH
Restoration/maintenance of blood volume
The first logical intervention is to restore an adequate blood
volume with fluid administration. Decreased urine output is
a hallmark of renal hypoperfusion, and restoring urine
output is an important target in acute renal failure. A
reduction in urine output is actually a more frequent sign of
acute renal failure than an increase in creatinine.32,33 There is
no good evidence that diuretics can protect the kidneys, and
some evidence that they may have harmful effects.34 There is
also evidence that edema formation, occurring as a result of
excess fluid administration, can alter tissue function.35 This
concept is also true in the kidney, where edema can result in
higher intracapsular pressures.36 In a large European study, in
which the time course of organ failure was studied, renal
failure was often preceded by a period of positive fluid
balance.37 Importantly, Macedo et al.38 reported that fluid
accumulation could dilute serum creatinine, thus leading to
underestimation of the increase in serum creatinine and
delayed diagnosis of renal dysfunction or failure.
It is therefore essential to carefully evaluate the volume
status of the patient, so as to avoid both hypo- and
hypervolemia. Assessing fluid requirements is, however, not
easy. Assessment of heart rate is neither sensitive nor specific.
In contrast to the typical pressure response to volume status
in chronic renal failure, the arterial pressure tells very little
about the fluid status in the critically ill. As arterial pressure
is determined by cardiac output and vascular tone, hypoten-
sion may result from alterations in any of the determinants of
cardiac function discussed above—hypovolemia, myocardial
failure, severe arrhythmia, or obstruction (as in massive
pulmonary embolism or tamponade)—or from profound
alterations in vascular tone, such as those that occur in severe
sepsis. Cardiac filling pressures provide very little informa-
tion regarding the volume status of an individual patient, and
can only give a statistical likelihood of a response to fluids,
from around 80% when the cardiac filling pressures are low
to less than 40% when they are high.39 The central venous
pressure may be elevated even in the presence of relative
hypovolemia in patients with pulmonary hypertension, such
as patients with chronic lung disease.
Ultimately, the response to fluids is characterized by an
increase in stroke volume associated with an increase in
cardiac filling, corresponding to a positioning on the
ascending limb of the Frank–Starling curve. For the tissues,
it is the resulting increase in cardiac output that will increase
oxygen transport.
Several techniques can be used to try to predict the
response to fluids. In patients under mechanical ventilation,
respiratory variations in stroke volume or its derivates (pulse
pressure, phlethysmography) are associated with a high
likelihood of hemodynamic response to fluids.40 Unfortu-
nately, these indices are not valid in patients with
arrhythmias, spontaneous ventilation, or low tidal volume,41
and thus these techniques can only be applied in selected
patients. In addition, perfect coordination with the respirator
requires deep sedation, which we prefer to avoid today.42
Indeed, all sedative agents alter vascular tone and may also
decrease myocardial contractility, thus altering the hemody-
namic status. The use of prolonged sedation also prolongs the
recovery phase and rehabilitation.
The passive leg raising test may also be used to predict
fluid responsiveness,43 but for this test patients must be able
to tolerate a rapid change in torso position (this may not be
the case in some surgical patients and in patients with
cerebral edema) and it requires the use of rapid response
cardiac output monitoring. Here, also, sedation may be
required to prevent stress-related sympathetic stimulation,
which may increase heart rate and cardiac output in all
individuals, regardless of their volume status.
In addition to the intrinsic limitations of these tests, one
should recognize that the results of these tests are not
dichotomic (i.e., no response below a given value, response
above that value); there is rather a continuum, with the
likelihood of response to fluids increasing when the value
increases, so that there remains a ‘gray zone’ in which there is
still some incertitude. Hence, these tests do not negate the
need for a fluid challenge.44 Rather, when physicians use
these tests to predict fluid responsiveness, it is still wise to use
a fluid challenge technique when administering the fluids in
order to ensure that the response to fluid is indeed positive
and that they are tolerated.
Ultimately, trial and error is the best approach. As an
example, what would we do if urine output increased by
40ml after administering 1 liter of intravenous fluids? Would
we continue infusion with the risk of creating a similar
positive fluid balance, i.e., almost one liter of fluid
accumulating in the body, or would we stop (and risk losing
the benefits?). The answer lies in the cardiac filling (pressures
or volumes). Because volumes represent ventricular preload
better than pressures, one may consider that measurements
of volume are of greater value. However, as edema formation
is dependent on intravascular pressures, it may be better to
base our decisions on filling pressures rather than volumes. In
addition, the relationship between pressures and volumes is
curvilinear so that pressures increase rapidly when a given
volume is exceeded.45 This is why the fluid challenge
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technique was developed,44 enabling the patient’s response to
fluids to be determined while minimizing the risks of edema
(pulmonary edema in particular).
When performing a fluid challenge, four items must be
defined in advance, which can be summarized by the
acronym, TROL:
1—Type of fluid (e.g., Ringer’s lactate)
2—Rate of infusion (e.g., 500ml in 30min)
3—Objective (e.g., increase in arterial pressure to
75mmHg or urine output greater than 20ml in 30min);
4—Limits (e.g., a maximal increase in central venous
pressure of 3mmHg from a baseline of 12mmHg).
If the target improves but is not reached with the fluid
challenge, and the safety limits are not breached, fluid
challenges can be repeated until such time as there is no
further improvement in the objective or the safety bound-
aries are exceeded. Repeated fluid challenges can thus be
given as long as the response suggests continuing hypovo-
lemia, thus limiting the risks associated with fluid overload.
Restoration/maintenance of perfusion pressure
When blood volume has been restored and fluid therapy is
no longer beneficial, vasoactive agents are needed to restore/
maintain perfusion pressure. In the hypotensive patient,
vasopressors should be used as the first-line strategy. The
choice of vasopressor agent has already been discussed above
and Figure 3 presents the effects of currently used vasoactive
agents on arterial pressure and cardiac output.
CONCLUSION
Cardiovascular alterations in the critically ill are complex and
not limited to low flow states. Sepsis, in particular, is a
frequent cause of renal failure in which renal blood flow is
typically preserved. In all cases, optimization of blood
volume and tissue perfusion pressure is of paramount
importance. A number of variables need to be combined to
build a complete picture, which will then enable appropriate
treatment choices to be made based on a sound physiological
approach.
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